Neonc Technologies Holdings NTHI
NASDAQ NTHI
$4.68 +0.12 (+2.52%)
At close: Aug 21, 2026 · 4:00 PM EDT

Neonc Technologies Holdings (NTHI) Accumulated Expenses (2024 - 2026)

Neonc Technologies Holdings (NTHI) posted quarterly Accumulated Expenses of $1.7 million for Q1 2026, up 282.87% year-over-year from $444766.0 in Q1 2025, and up 128.54% quarter-over-quarter from $745118.0 in Q4 2025.

Neonc Technologies Holdings (NTHI) Accumulated Expenses (2024 - 2026) Analysis & Trends

Neonc Technologies Holdings (NTHI) has reported Accumulated Expenses for 3 consecutive years, with $1.7 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Accumulated Expenses rose 282.87% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 282.87% YoY), while the FY2025 annual figure was $745118.0, up 1.39% from the prior year.
  • Accumulated Expenses grew to $1.7 million in Q1 2026 per NTHI's latest filing, from $745118.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $1.7 million in Q1 2026 and bottomed at $255099.0 in Q2 2025.
  • Historically, Accumulated Expenses has averaged $689638.8 across 3 years, with a median of $589820.0 in 2024.
  • Annual changes were most pronounced in 2025 — Accumulated Expenses climbed 1.39% — and 2026, when it soared 282.87%.
  • Neonc Technologies Holdings' Accumulated Expenses stood at $734874.0 in 2024, then climbed by 1.39% to $745118.0 in 2025, then soared by 128.54% to $1.7 million in 2026.
  • Business Quant data shows NTHI's Accumulated Expenses at $1.7 million in Q1 2026, $745118.0 in Q4 2025, and $255099.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Neonc Technologies Holdings 116.41 Mn 116.41 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 2.05 Mn
Mar 31, 2026 1.70 Mn
Dec 31, 2025 745,118.00
Sep 30, 2025 255,099.00
Jun 30, 2025 255,099.00
Mar 31, 2025 444,766.00
Dec 31, 2024 734,874.00